SG11202109928WA - Pharmaceutical composition for treating aortic aneurysm - Google Patents

Pharmaceutical composition for treating aortic aneurysm

Info

Publication number
SG11202109928WA
SG11202109928WA SG11202109928WA SG11202109928WA SG 11202109928W A SG11202109928W A SG 11202109928WA SG 11202109928W A SG11202109928W A SG 11202109928WA SG 11202109928W A SG11202109928W A SG 11202109928WA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
aortic aneurysm
treating aortic
treating
aneurysm
Prior art date
Application number
Inventor
Naoki Unno
Hiroki Tanaka
Tatsuro YATA
Takafumi KAYAMA
Keisuke Inoue
Kiyoshi Toya
Original Assignee
National Univ Corporation Hamamatsu Univ School Of Medicine
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Univ Corporation Hamamatsu Univ School Of Medicine, Kowa Co filed Critical National Univ Corporation Hamamatsu Univ School Of Medicine
Publication of SG11202109928WA publication Critical patent/SG11202109928WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
SG11202109928W 2019-03-13 2020-03-13 Pharmaceutical composition for treating aortic aneurysm SG11202109928WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019045333 2019-03-13
PCT/JP2020/011042 WO2020184703A1 (en) 2019-03-13 2020-03-13 Pharmaceutical composition for treating aortic aneurysm

Publications (1)

Publication Number Publication Date
SG11202109928WA true SG11202109928WA (en) 2021-10-28

Family

ID=72427139

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202109928W SG11202109928WA (en) 2019-03-13 2020-03-13 Pharmaceutical composition for treating aortic aneurysm

Country Status (11)

Country Link
US (1) US20220184058A1 (en)
EP (1) EP3939656A4 (en)
JP (1) JPWO2020184703A1 (en)
KR (1) KR20210144657A (en)
CN (1) CN113316469A (en)
BR (1) BR112021018017A2 (en)
CA (1) CA3133209A1 (en)
MX (1) MX2021010987A (en)
SG (1) SG11202109928WA (en)
TW (1) TW202100155A (en)
WO (1) WO2020184703A1 (en)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444784A (en) 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
DK149080C (en) 1980-06-06 1986-07-28 Sankyo Co METHOD FOR PREPARING ML-236B CARBOXYLIC ACID DERIVATIVES
JPS572240A (en) 1980-06-06 1982-01-07 Sankyo Co Ltd Ml-236b derivative
JPS60500015A (en) 1982-11-22 1985-01-10 サンド・アクチエンゲゼルシヤフト Mevalolactone congeners and their derivatives, their production methods and pharmaceutical compositions containing them
US5354772A (en) 1982-11-22 1994-10-11 Sandoz Pharm. Corp. Indole analogs of mevalonolactone and derivatives thereof
JP2569746B2 (en) 1987-08-20 1997-01-08 日産化学工業株式会社 Quinoline mevalonolactones
FI94339C (en) 1989-07-21 1995-08-25 Warner Lambert Co Process for the preparation of pharmaceutically acceptable [R- (R *, R *)] - 2- (4-fluorophenyl) -, - dihydroxy-5- (1-methylethyl) -3-phenyl-4 - [(phenylamino) carbonyl] -1H- for the preparation of pyrrole-1-heptanoic acid and its pharmaceutically acceptable salts
JP2648897B2 (en) 1991-07-01 1997-09-03 塩野義製薬株式会社 Pyrimidine derivatives
TW338037B (en) 1995-10-05 1998-08-11 Otsuka Pharma Co Ltd Carbostyril derivatives possessing platelet aggregation inhibitory activity, antithrombotic activity, intima thinkening, inhibitory activity and phosphoriesterase inhibitory activity, their preparation and pharmaceutical composition
PT1894576E (en) * 2005-06-08 2011-07-29 Kowa Co Novel triglyceride reducing agent
JP2007230884A (en) * 2006-02-28 2007-09-13 Kowa Co Prophylactic and/or curative agent for vertebral canal stegnosis
JPWO2013103148A1 (en) * 2012-01-05 2015-05-11 興和株式会社 Collateral circulation development promoter
JP6367581B2 (en) * 2014-03-18 2018-08-01 国立大学法人浜松医科大学 Aneurysm reducing agent

Also Published As

Publication number Publication date
JPWO2020184703A1 (en) 2020-09-17
WO2020184703A1 (en) 2020-09-17
CN113316469A (en) 2021-08-27
MX2021010987A (en) 2021-12-15
EP3939656A1 (en) 2022-01-19
BR112021018017A2 (en) 2021-11-23
KR20210144657A (en) 2021-11-30
US20220184058A1 (en) 2022-06-16
TW202100155A (en) 2021-01-01
CA3133209A1 (en) 2020-09-17
EP3939656A4 (en) 2022-12-07

Similar Documents

Publication Publication Date Title
GB201911928D0 (en) Pharmaceutical compounds
IL290843A (en) Submucosal bioresorbable drug eluting platform
GB201911944D0 (en) Pharmaceutical compounds
GB201911517D0 (en) Pharmaceutical composition
GB2584277B (en) Dental stent
IL291570A (en) Pharmaceutical compounds
GB201914910D0 (en) Pharmaceutical compounds
GB201807053D0 (en) Pharmaceutical composition
SG11202109928WA (en) Pharmaceutical composition for treating aortic aneurysm
SG11202110315SA (en) Pharmaceutical composition
FI3908321T3 (en) Pharmaceutical composition
IL278964A (en) Pharmaceutical compositions for treating acid sphingomyelinase deficiency
SG11202105231UA (en) Pharmaceutical composition for treating wounds
KR102324922B9 (en) Pharmaceutical composition comprising osteocalcin for preventing or treating inflammatory diseases
EP4081251A4 (en) Pharmaceutical compositions
GB201915932D0 (en) Pharmaceutical compounds
GB201915273D0 (en) Pharmaceutical compounds
EP3682886A4 (en) Pharmaceutical composition for treatment of aortic aneurysm
IL289213A (en) Pharmaceutical composition for treating tumor
IL285728A (en) Pharmaceutical composition
EP3782603C0 (en) Pharmaceutical composition for treating gout
GB201912686D0 (en) Pharmaceutical composition
GB201908003D0 (en) Pharmaceutical composition
EP3993801A4 (en) Pharmaceutical composition for treating insomnia
KR102316726B9 (en) Medicinal composition for treating wound